Hepatitis A is a virus that infects the liver. Symptoms usually take 15-50 days to develop after initial infection and typically last for several weeks or sometimes longer.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Hepatitis
Menampilkan 21 - 29 dari 29 artikel
Hepatitis viruses are serious infections that damage the liver. There is an urgent need to deal with increased Hepatitis B infections in Kenya.
Women have evolved to have stronger immunity than men. But this comes with downsides -
women are more likely to have autoimmune diseases due to their “reactive” immune systems.
Australia has been subsidising drugs to cure hepatitis C since March 2016. Unlike in many other countries, these are available to everyone with the disease and are much cheaper for our government.
Viral hepatitis sheds light on key challenges faced by health system in Africa and how social and culture factors can help in prevention.
Ghana must urgently implement strategies to tackle the high burden of viral hepatitis if it’s to fulfill global targets of eliminating the disease by 2030.
Combinations of two or three hepatitis C virus direct-acting antiviral drugs taken for 8-24 weeks can cure more than 90% of people treated.
Hepatitis A, B, C, D and E are very different viruses. Hepatitis A is genetically closer to the common cold than it is to hepatitis B. Hepatitis C is closer to the virus that causes dengue fever.
Most people are aware of the benefits of breastmilk, but few are aware of the risks.
Kontributor teratas
-
Associate Research Scientist, African Population and Health Research Center
-
Communications Officer, African Population and Health Research Center
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Infectious Diseases Physician, St Vincent's Hospital, Sydney; Scientia Professor, Kirby Institute, UNSW Sydney
-
Associate Professor of Microbial Bioinformatics, Nottingham Trent University
-
Professor of Immunology and Director of Research, Moi University
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Sociologue, chargée de recherche, Centre Population & Développement (CEPED), Institut de recherche pour le développement (IRD)
-
University of Nairobi
-
Research Officer, Kenya Medical Research Institute
-
Research Fellow at Monash University, Monash University
-
Epidemiologist, WHO Collaboating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Honorary Clinical Associate Professor, University of Glasgow
-
Manager, Centre for Genome-Enabled Biology & Medicine, University of Aberdeen
-
Senior research scientist, Walter and Eliza Hall Institute
